POLISH PHARMACEUTICAL INDUSTRY

• Document Type: CREST
• Collection: General CIA Records
• Document Number (FOIA) /ESDN (CREST): CIA-RDP80T00246A026800090001-5
• Release Decision: RIPPUB
• Original Classification: S
• Document Page Count: 5
• Document Creation Date: December 27, 2016
• Document Release Date: October 30, 2013
• Sequence Number: 1
• Publication Date: September 16, 1957
• Content Type: REPORT

A
Declassified in Part- Sanitized Copy Approved forRelease2013/10/30 : CIA-RDP80T00246A026800090001-5
I I
CENTRAL INTELLIGENCE AGENCY
This material contains information affecting the National Defense of the United States within the meaning of the Espionage Laws, Title
18, U.S.C. Secs. 793 and 794, the transmission or revelation of which in any manner to an unauthorized person is prohibited by law.
S E C R.E T
50X1 -HUM
COUNTRY Poland
SUBJECT Polish Pharmaceutical Industry
50X1
REPORT
DATE DISTR.
le SEP 1957
NO. RAGES
5
REQUIREMENT
NO.
RD
DATE OF
REFERENCES
INFO.
PLACE &
50X1 -HUM
DATE ACQ.
SOURCE EVALUATIONS ARE DEFINITIVE. APPRAISAL OF CONTENT IS TENTATIVE
50X1 -HUM
1. The Central Administratioa for the Pharmaceutical Industry (Centralny
Zarzad PrzemysluFarmaceuticzLego), which has 100 employees, is located at
No. 3 Mysia Stroct? Warsaw ? and is under the Ministry for the Chemical
Industry. The Administration also maintains a ftarmace,Itical Scientific
Institute, with two branches, one at the Pharmaceutical Works at Tarchomin,
and the other one at the Krakow Pharmaceuttcal Works. The central plant at
Warsaw has some 200 emp/oyees. In 1956, a special department for the
production of streptomycin was established at that plant.
2. The plants whisi'h are controlled by the Central Administration are ,of two
types:
a. Plants preparing pharmaceutical prodixts from basic materials:
b. Plants manufacturing medicamemts and drugs.
3. The plants preparing pharmaceutical products from basic- materials are as
follows;
a. The TarchominPasmactuacoliNcrks(Tarchominskie Zaklady Farmaceutyczne),
located at No. 19 Fabryczaa Street, Tarchomin, which is the largest enter-
prise of its kind in Poland. It was put into operation Immediately
after World War II? using what had been left of the prewar plant of
Spies i Synowie. Some 1,800 persons are employed, including 350
administrative personnel. The plant has three production divisions:
for penicillin, for synthesis, and for medical preparations and injections.
In addition to the above mentioned there are auxiliary divisions, such as
a workshop, power station, and carpentry.
(1) The Penicillin Production Division produces penicillin and divides
it into units (dozvle) for use0 it also divides into units 50X1 -HUM
streptomycin The entire equipment
of the division is of foreign make; Poland does not manufacture
equipment for the production of antibiotics. The division is equipped
with ten 11,000 - liter tanks for fermentation of the penicillin-
proaucing fungi (Szczep Penicyliro Tworczy). Until the beginning of
1957, penicillin-producing cultures were imported from the USSR.
SECRET
STATE X ARMY NAVY
50X1 -HUM
AIR
FBI
AEC
(Note: Washington distribution indicated by "X"; Field distribution by "#".)
INFORMATION REPORT._ INFORMATION REPORT
,
Declassified in Part - Sanitized Copy Approved for Release 2013/10/30: CIA-RDP80T00246A026800090001-5
Declassified in Part-Sanitized Copy Approved for Release 2013/10/30: CIA-RDP80T00246A026800090001-5
SECRET
50X1
50X1-HUM
In January 1957; cultures were imported because these 50X1-HUM
cultures were producing at a larger rate than the ones imported from
the USSR. In 1956 the department produced 6,700 million 4nits of
penicillin; by 1957, with the use of Soviet-produced cultures.,
production rose to 800 million-.units? while after 50X1-HUM
had. been put to use, production was estimated at about 2,000 million
units. The quality of the penicillin is not high. A number of foreign
Intrchasers? mainly China, have complained of the low quality.
(2) The Synthesis Division is the second. largest in the plant. It manufactures
barbiturates, Vitamin D2, Acetarsol, Nova.rsany Polocain. The equipment'G '
of the division dates back to prewar times.: Only the "reactors"
(Reaktory) were brought from Hungary and. Germany after World War II,
The products are not of the same quality,. Acetarsol and.Tthlocain are
of high standard, the barbiturates do not come up to standaz* sdi'..Novarsan
was taken off the market because of its poor quality and its*,p0dattion.
was discontinued. For the same reason, as well as because-Of high
production costs, the production of Vitamin D2 has also aspontimiett,
In 1956 the division manufactured 910001toot Poloca.in, and. in 1957 it
plans to manufacture 12,000 kg.
(3) The Medicaments and Injections Division produces insulin and, lf,epafort,
and, in addition, manufactures and divides into units prep ins.
produced by other divisions. The equipment for the production or
and of Ilepafort is modern. Insulin was produced. on a commercial .baElit5
only in 1956d According to plan, 250 billion units of insulin will be
produced in 1957. The quality, however, is poor,
b. The Krakow Pharmaceutical Works (Krakowskie Zaklady Farmaceutyczne), which
is located in the Podgarze district of Krakow. Established after World
War II, it now employs 4300-1,400 workers. The plant produces sumo/Wein
and vitamins.
c. The Pharmaceutical Works of Starogard? near Gdansk (Starogard.skie Zaklady
Farmaceutyczne)) established after World War II, which employs 1,100 to
1,200 workers, and manufactures sulfonamides (Sulfamidy) (8 to 9 tons per
annum).
d. The Foch Works at Gliwice (Gleiwitz) (Fabryka Odczynnikow "Foch" Gliwice)
which is a temporary, experimental plant, and. employs 800 to 900 workers,
e. Pabianice Chemical Works (Zaklady Przemyslu Chemicznego Pabianice).
f. Kutno Pharmaceutical Works (Kutnowskie 7a.klAdy Farmaceutyczne) which is a
morphium-producing plant.
4. The plants which Inanufacture medicaments and drugs are as follows:
a. Warsaw Pharmaceutical Works (Warszawskie Zaklady Farmaceutyczne) on
Karolkowa Street, Warsaw. This plant, formerly known, as the Clave plantp
employs some 1,000 workers, produces injectors, and manufactureadicaments
from semifinished materials.
b. The Motor PharmaceuticalWOrks on Raclawicka Street, Warsaw (Za.klady
Farmaceutyczne Motor - W-Wa). This plant is made up ,of a number Of?fiamer
private enterprises expropriated by the government, such ast The Motor
Works, Mokotow district, the Roztkowski Works at Radose, near Warsaw, and.
anOthfIr plant in the Wola district.
qprIPPM
50X1-HUM
Declassified in Part-Sanitized Copy Approved for Release 2013/10/30: CIA-RDP80T00246A026800090001-5
Declassified in Part - Sanitized Copy Approved for Release 2013/10/30: CIA-RDP80T00246A026800090001-5
SECRET
50X1
50X1 -HUM
t. The. Jelenia Gore PharmaceuticalWOrke (Jeleniogorskie Zaklady FarmaceutyCzne)?
a former German plant, which employs 800 persons.
?d. The Lodz PharmaceuticalAnice (Lodzkie Zaklady Farmaceutyczne), a snail
?
Laant.
e. The Chirurgofil Plant, at Poznan) a small plant with only 150 employees,
which produces surgical yarn only This plant it'hotehle to meet aIL
Polish requirements, therefore certain quantities of this commodity are
imported.
5. The folloying pertains to the import of medicaments and basil. 1111'''''''''44""fi Pal 50X1-HUM
materials. In 1956 three tons Of streptomycin were imported I 4
tons are scheduled to be imported in 1957. Large quantitites of aureomycin and
Vitamin B12 were imported in 1956. Qther items imported in the sams'
year were: 12 tons ,of caffeine, from East Germany, 18-20 kg. Vitamin D21 from 50X1-HUM
Hungary; large quantities of Novarsan from the USSR, however, of low quality.
Efforts are ,made to produce It locally, .b without success.
6, Exports of medicaments have been as follows: In 1955 and 1956, 400 billion units
of penicillin were sold to China (or 400 billion units annually). No further
:orders were placed by China for 1957) since it was claimed that the penicillin
delivered had been Of inferior quality. Poland dispatched a special commission
to China in order to investigate this claim, which was subsequently found to 50X1-HUM
be baseless. The real reason was apparently the fact that the Chinese-preferr-1
to buy the cheaper penicillin powder and proress it themselves. 50X1-HUM
Seven hundred billion units of penicillin were exported I in 1956
Penicilli n
exports to Rumania were discontinued as well, since Rumania had meanwhile 50X1 -HUM
established a penicillin industry of her own.
7. IA 1 6 Poland exported tour tons of Polocain
and 400 kg. of Acetarsol (a medicine used in the treatment of plague)
50X1 -HUM
50X1 -HUM
8. Quantitles of pharmaceutical production:
a. PolOcain: In 1956 the ,output was ten tons) six _?of Nch were for local
use and four for export. The annual output for 1957 is scheduled to be 14
tong.
b. Penicillin: The ,output for 1956 was 6,700 billion unitsi which is to be
increased in 1957 to 201000 billion units
50X1 -HUM
I.
c. Sulfonamides (sulfamidy): The total output in Poland for 1956 was 40 tons.
Insulin: Production target for 1957 is 250 billion units.
Hepafort: The output for 1956 was 5,000 liters*
f.? Barbiturates: The output TOr 1956 was 17 tons (sleeping pills and local
anaesthetics). Production target for 1957 is 20 tons.
9. At Tarchomin? where the entire Polish production of penicillin is concentrated)
new divisions will be added until 1966; for the production of Vitamin B12?
aureomycinl terramycin and. streptomycin. The penici1lin-producing division
is also to be expanded, and will include the building of premises to house
fermentation tanks.
S E .0 R E T
50X1 -HUM
Declassified in Part - Sanitized Copy Approved for Release 2013/10/30: CIA-RDP80T00246A026800090001-5
Declassified in Part - Sanitized Copy Approved for Release 2013/10/30: CIA-RDP80T00246A026800090001-5
S E C R E T
10. Some of the persons connected with the Pharmaceutical Industry in Poland are-
as follows:
50X1
50X1 -HUM
a. Jan Antosiewicz. a licensed Pharmacist and chigf engineer at the Tarchomin
plant.
b. Zygmunt:_Gmaj? a licensed pharmacist, Director of the Tarchomin plant and
Co
until 1953 ,director of the Starogard Plant.
50X1 -HUM
50X1 -HUM
Kalandyk (fnu)? chemical engineer and chief engineer at the Central Admi7istration
Of the Pharmaceutical Industry (CZPF).
50X1 -HUM
Kodhan (fnu), Deputy Director of the-CZPF in charge of finance- and trade.
50X1 -HUM
e. Henryk Konary licensed pharmacist, Director of the CM%
the Jelenia0ora Pharmaceutical Works until 1952.
50X1 -HUM
and a diredtorof
f. Zenon Kycinski, Deputy Directorfor-Xommercial Affairs at o_
Tarchomiax
50X1 -HUM
g.? JUlian Lason, Deputy Director for Investment Affairs at the Tarthomin Plant
previously Deputy Commander at the. Dzierzynski MilitaryPolitical College
in Warsaw. 50X1 -HUM
h. Mamrot, (fnu). Deputy Director of the CZPF: deals with investments
11. The following is the legend to the sketch of the Tarchomin Pharmaceutical
Works found on Page 5.
1. Office buildings
2. Penicillin Division - Fermentation and Extraction (two-story building)
3. Penicillin Division - Packing (two-story building)
4. Mechanical workshop
5. Synthesis Division
6. Komprosorowna Department of Penicillin
7. Unidentified (probably a rail siding)
8. Raw materials store
9. Technical materials store (tools spare partsy etc.)
10. Boiler Division (new)
11. Water tower
12. Barbiturates Division
13. Boiler Division (old)
14. Store of finished products and of packing material
15. Insulin-Producing Division (two-floor building)
16. Repafort and Injections Division (one-story building)
17. Production room, divided into units? etc.
18. Fire brigade and garages
19. Workshops (carpentry shop, etc.)
20. Building Components Plant (Zaklady Produkcji Elementow Budowlanych)
21. Club house of the Tarchomin Plant
SECRET
50X1 -HUM
Declassified in Part - Sanitized Copy Approved for Release 2013/10/30: CIA-RDP80T00246A026800090001-5
Declassified in Part - Sanitized Copy Approved for Release 2013/10/30: CIA-RDP80T00246A026800090001-5
r
S1 C-1,2.R1'
-5-
50X1
50X1-HUM
SECRET
50X1-HUM
]I Declassified in Part - Sanitized Copy Approved for Release 2013/10/30: CIA-RDP80T00246A026800090001-5